Compare CLLS & OZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CLLS | OZ |
|---|---|---|
| Founded | 1999 | 2020 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.0M | 194.7M |
| IPO Year | 2014 | 2020 |
| Metric | CLLS | OZ |
|---|---|---|
| Price | $1.13 | $30.83 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $4.45 | N/A |
| AVG Volume (30 Days) | ★ 86.1K | 17.2K |
| Earning Date | 11-12-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $9,187,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 243.44 |
| 52 Week Low | $0.88 | $29.52 |
| 52 Week High | $5.45 | $69.00 |
| Indicator | CLLS | OZ |
|---|---|---|
| Relative Strength Index (RSI) | 47.78 | 25.28 |
| Support Level | $0.94 | N/A |
| Resistance Level | $1.28 | $35.25 |
| Average True Range (ATR) | 0.12 | 1.17 |
| MACD | 0.06 | -0.08 |
| Stochastic Oscillator | 40.01 | 18.76 |
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
Belpointe PREP LLC is a qualified opportunity fund. The company's investments consist of properties located in qualified opportunity zones for the development or redevelopment of multifamily, student housing, senior living, healthcare, industrial, self-storage, hospitality, office, mixed-use, data centers, and solar projects located throughout the United States and its territories. Company currently has two reporting segments, commercial: includes properties such as office, retail centers, and warehouses; and mixed-use: includes properties that blend both residential and retail components within a single real estate asset. The majority of the revenue is earn from mixed-use segment.